Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice



      Obstructive sleep apnea causes intermittent hypoxia (IH) and is associated with increased cardiovascular mortality. This increased risk may be attributable to more extensive or unstable atherosclerotic plaques in subjects with OSA. We studied the effect of chronic IH in atherosclerosis-prone mice.

      Methods and results

      Apolipoprotein E-deficient (ApoE−/−) mice fed a high cholesterol diet were exposed to 4 or 12 weeks of IH and compared to intermittent air-exposed controls. At 4 weeks, IH increased plaque size in the aortic sinus and the descending aorta. At 12 weeks, atherosclerosis progressed in all groups, but more rapidly in the descending aorta of IH-exposed animals. Plaque composition was similar between IH and controls. Between 4 and 12 weeks, there were progressive increases in blood pressure, with relatively stable increases in serum lipids and arterial stiffness.


      IH accelerates atherosclerotic plaque growth in ApoE−/− mice without affecting plaque composition. The mechanisms may include non-additive increases in serum lipids, and cumulative increases in blood pressure.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) final report
        Circulation. 2002; 106: 3143-3421
        • Halvorsen B.
        • Otterdal K.
        • Dahl T.B.
        • et al.
        Atherosclerotic plaque stability—what determines the fate of a plaque?.
        Prog Cardiovasc Dis. 2008; 51: 183-194
        • Libby P.
        • Geng Y.J.
        • Sukhova G.K.
        • Simon D.I.
        • Lee R.T.
        Molecular determinants of atherosclerotic plaque vulnerability.
        Ann N Y Acad Sci. 1997; 811: 134-142
        • Young T.
        • Palta M.
        • Dempsey J.
        • et al.
        The occurrence of sleep-disordered breathing among middle-aged adults.
        N Engl J Med. 1993; 328: 1230-1235
        • Young T.
        • Finn L.
        • Peppard P.E.
        • et al.
        Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort.
        Sleep. 2008; 31: 1071-1078
        • Punjabi N.M.
        • Caffo B.S.
        • Goodwin J.L.
        • et al.
        Sleep-disordered breathing and mortality: a prospective cohort study.
        PLoS Med. 2009; 6: e1000132
        • Drager L.F.
        • Bortolotto L.A.
        • Figueiredo A.C.
        • Krieger E.M.
        • Lorenzi-Filho G.
        Effects of CPAP on early signs of atherosclerosis in obstructive sleep apnea.
        Am J Respir Crit Care Med. 2007; 176: 706-712
        • Peppard P.E.
        • Young T.
        • Palta M.
        • Skatrud J.
        Prospective study of the association between sleep-disordered breathing and hypertension.
        N Engl J Med. 2000; 342: 1378-1384
        • McArdle N.
        • Hillman D.
        • Beilin L.
        • Watts G.
        Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study.
        Am J Respir Crit Care Med. 2007; 175: 190-195
        • Robinson G.V.
        • Pepperell J.C.
        • Segal H.C.
        • Davies R.J.
        • Stradling J.R.
        Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials.
        Thorax. 2004; 59: 777-782
        • Lavie L.
        • Vishnevsky A.
        • Lavie P.
        Evidence for lipid peroxidation in obstructive sleep apnea.
        Sleep. 2004; 27: 123-128
        • Savransky V.
        • Nanayakkara A.
        • Li J.
        • et al.
        Chronic intermittent hypoxia induces atherosclerosis.
        Am J Respir Crit Care Med. 2007; 175: 1290-1297
        • Meir K.S.
        • Leitersdorf E.
        Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress.
        Arterioscler Thromb Vasc Biol. 2004; 24: 1006-1014
        • Hartley C.J.
        • Taffet G.E.
        • Michael L.H.
        • Pham T.T.
        • Entman M.L.
        Noninvasive determination of pulse-wave velocity in mice.
        Am J Physiol. 1997; 273: H494-H500
        • Tangirala R.K.
        • Rubin E.M.
        • Palinski W.
        Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.
        J Lipid Res. 1995; 36: 2320-2328
        • Gidez L.I.
        • Miller G.J.
        • Burstein M.
        • Slagle S.
        • EDER H.A.
        Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.
        J Lipid Res. 1982; 23: 1206-1223
        • Guo Z.
        • Mitchell-Raymundo F.
        • Yang H.
        • et al.
        Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficient mice.
        Mech Ageing Dev. 2002; 123: 1121-1131
        • Li J.
        • Thorne L.N.
        • Punjabi N.M.
        • et al.
        Intermittent hypoxia induces hyperlipidemia in lean mice.
        Circ Res. 2005; 97: 698-706
        • Li J.
        • Savransky V.
        • Nanayakkara A.
        • et al.
        Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia.
        J Appl Physiol. 2007; 102: 557-563
        • Sniderman A.D.
        • Cianflone K.
        Substrate delivery as a determinant of hepatic apoB secretion.
        Arterioscler Thromb. 1993; 13: 629-636
        • Li J.
        • Nanayakkara A.
        • Jun J.
        • Savransky V.
        • Polotsky V.Y.
        Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia.
        Physiol Genomics. 2007; 31: 273-280
        • Fletcher E.C.
        • Lesske J.
        • Culman J.
        • Miller C.C.
        • Unger T.
        Sympathetic denervation blocks blood pressure elevation in episodic hypoxia.
        Hypertension. 1992; 20: 612-619
        • Kumar G.K.
        • Rai V.
        • Sharma S.D.
        • et al.
        Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress.
        J Physiol. 2006; 575: 229-239
        • Dematteis M.
        • Julien C.
        • Guillermet C.
        • et al.
        Intermittent hypoxia induces early functional cardiovascular remodeling in mice.
        Am J Respir Crit Care Med. 2008; 177: 227-235
        • Tsioufis C.
        • Thomopoulos K.
        • Dimitriadis K.
        • et al.
        The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects.
        J Hypertens. 2007; 25: 141-146
        • Drager L.F.
        • Bortolotto L.A.
        • Krieger E.M.
        • Lorenzi-Filho G.
        Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis.
        Hypertension. 2009; 53: 64-69
        • Lavie L.
        • Lavie P.
        Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link.
        Eur Respir J. 2009; 33: 1467-1484
        • Jun J.C.
        • Savransky V.
        • Nanayakkara A.
        • et al.
        Intermittent hypoxia has organ-specific effects on oxidative stress.
        Am J Physiol Regul Integr Comp Physiol. 2008; 295: R1274-R1281
        • Jun J.
        • Polotsky V.Y.
        Sleep disordered breathing and metabolic effects: evidence from animal models.
        Sleep Med Clin. 2007; 2: 263-277
        • Raguso C.A.
        • Guinot S.L.
        • Janssens J.P.
        • Kayser B.
        • Pichard C.
        Chronic hypoxia: common traits between chronic obstructive pulmonary disease and altitude.
        Curr Opin Clin Nutr Metab Care. 2004; 7: 411-417